New precision oncology paradigm integrates single-cell transcriptomics, regulatory community inference and AI to determine and goal co-existing malignant cell states, with analysis in pancreatic most cancers revealing six conserved most cancers cell states.
New paradigm integrates single-cell transcriptomics, regulatory community inference, and AI to decode—and therapeutically goal—the a number of, co-existing most cancers cell states that drive resistance in pancreatic most cancers, glioblastoma, and different deadly malignancies
DarwinHealth, a New York-based, AI-centric biotechnology firm. introduced the introduction of Quantum Most cancers Biology: A Cell-State Programs Biology Framework for Precision Oncology, a transformative scientific paradigm designed to deal with certainly one of oncology’s best unsolved challenges: why the world’s deadliest cancers proceed to evade even essentially the most superior focused therapies.
The announcement accompanies the publication in Nature Genetics (https://www.nature.com/articles/s41588-026-02714-8) of a brand new perspective led by Dr. Andrea Califano and Dr. Kenneth P. Olive, pushed by first creator Dr. Pasquale Laise, PhD, alongside co-first authors Mikko Turunen, PhD, and Alvaro Curiel-Garcia, PhD.
The research, performed at Columbia College, presents authentic analysis findings and argues that the following revolution in oncology won’t come from discovering a single “miracle drug,” however from longitudinally decoding the a number of malignant mobile states that coexist inside superior, treatment-resistant tumors in particular person sufferers.
The framework, undergirded by the corporate’s proprietary VIPER know-how, licensed by Columbia solely to DarwinHealth, is supported by pioneering analysis led by DarwinHealth scientists Pasquale Laise, Mariano J. Alvarez, Andrea Califano, and their collaborators. Their single-cell programs biology research, together with the simply printed Nature Genetics report, reveal that pancreatic cancers comprise not one, however a number of, biologically distinct malignant cell states, every ruled by distinctive regulatory applications and therapeutic vulnerabilities.
From a landscape-changing perspective, that is the primary research to convincingly present that vulnerabilities and desired drug responses amongst a number of most cancers cell states that coexist in a person affected person’s tumor (on this case, pancreatic most cancers) are nearly identically conserved in sufferers with the identical form of most cancers. In different phrases, on the time of illness onset, all sufferers with a specific form of most cancers—pancreatic most cancers, glioblastoma, breast most cancers, melanoma, prostate most cancers, and lots of others—harbor a recurring, predictable, and co-existing mixture of a number of most cancers cell state abnormalities, all of which should be focused comparatively concurrently to realize optimum therapy outcomes.
By extension, enduring therapy responses—and most significantly, definitive cures—particularly for our most deadly and resistant tumors, will probably come, not from any single bullet, however from decoding the most cancers cell states after which deploying multi-drug mixtures directed at every irregular state early within the therapy course. Because the research reveals, each decoding and focusing on methods may be systematically recognized utilizing AI-based algorithms, akin to these developed and commercialized by DarwinHealth.
Collectively, the advances reported in Nature Genetics set up the scientific foundations and drug improvement roadmaps for a brand new technology of precision oncology therapies based mostly not merely on figuring out genetic mutations, however on decoding the regulatory structure that determines how each malignant cell behaves—and the way it may be therapeutically eradicated. Primarily based on these current outcomes, in addition to earlier and yet-to-come research, these applied sciences developed and refined by DarwinHealth are paving the way in which to extra common and more practical mixture therapies for cancers proven to be proof against present therapies and, subsequently, answerable for invariably excessive mortality charges, regularly in extra of 90%.
Past Precision Oncology
For many years, precision oncology has largely outlined tumors by their genomic mutations, with therapies designed to inhibit particular person oncogenic drivers. Whereas this technique has produced necessary scientific advances, sturdy responses in extremely resistant cancers akin to pancreatic most cancers and glioblastoma stay unusual as a result of tumors frequently evolve new, resistant mobile populations.
Quantum Most cancers Biology proposes a basically completely different view.
Moderately than treating most cancers as a single illness, the framework acknowledges every tumor as a dynamic ecosystem composed of a number of interacting malignant cell states. Every mobile state is managed by its personal regulatory circuitry, possesses its personal survival mechanisms, and reveals its personal therapeutic sensitivities.
The central problem, subsequently, isn’t merely figuring out a mutation—it’s figuring out —and on this case, utilizing AI to decode—each clinically related most cancers cell state inside a person affected person’s tumor and figuring out the optimum therapeutic technique for every.
DarwinHealth co-founder Califano has additionally lately printed a overview within the journal Cell, “Fifteen challenges for generative AI purposes to cell biology” (https://www.cell.com/cell/fulltext/S0092-8674(26)00802-0), additional illuminating the position of AI for network-based predictions to information most cancers therapy.
Making the Invisible Seen
DarwinHealth’s drug discovery platform leverages single-cell transcriptomics, AI, and regulatory community inference to deduce grasp regulatory protein exercise. The corporate’s know-how rigorously validates the useful actuality and causality of those mobile states by way of multi-modal integration with ATAC-seq, lineage tracing, and CRISPR perturbations.
Not like typical gene-expression profiling—which merely catalogs transcript abundance—DarwinHealth’s programs biology framework pinpoints the causal drivers sustaining malignant states and identifies the molecular checkpoints almost definitely to break down them.
This method transforms advanced tumor landscapes into high-resolution useful maps, revealing beforehand invisible targets for precision oncology.
Pancreatic Most cancers because the Prototype
The facility of this method is illustrated by the unique work simply printed in Nature Genetics.
Utilizing regulatory community evaluation of single-cell transcriptomic information, the investigators recognized six extremely conserved malignant pancreatic most cancers cell states organized into three developmental lineages. Importantly, these regulatory states proved remarkably reproducible throughout impartial affected person cohorts, pancreatic most cancers cell strains, and patient-derived xenograft fashions, offering a sturdy mechanistic taxonomy of pancreatic most cancers heterogeneity.
Moderately than merely describing tumor variety, the investigators recognized the Grasp Regulator proteins answerable for sustaining every malignant state and experimentally demonstrated that these regulatory applications signify therapeutically actionable mobile dependencies.
These findings present a mechanistic roadmap for growing rational mixture therapies able to concurrently focusing on a number of malignant populations inside a single tumor.
Towards Rational Mixture Remedy for Most cancers
Drug resistance stays the main explanation for mortality in sufferers with superior most cancers.When one therapeutic agent efficiently eliminates drug-sensitive cells, resistant populations regularly survive, broaden, and finally repopulate the tumor.
Quantum Most cancers Biology reframes this downside.
As an alternative of asking which single drug finest treats a tumor, the framework asks:
Which mixture of therapeutics is required to remove each biologically distinct malignant cell state that exists inside that affected person’s most cancers?
By computationally figuring out these states and their regulatory dependencies, DarwinHealth seeks to allow the rational design of multi-agent therapeutic methods that tackle the entire mobile structure of resistant cancers, slightly than solely their dominant populations. This idea aligns with the corporate’s broader perspective on treating tumors as advanced “oncosystems.”
Management Views
“The way forward for precision oncology lies in understanding the regulatory logic that determines mobile identification—not merely cataloging mutations or measuring gene expression. By reconstructing the regulatory networks that management particular person most cancers cell states, we are able to determine the molecular mechanisms that maintain them and, finally, the therapeutic methods able to disrupting them.”
— Andrea Califano, Dr.
Co-Founder, DarwinHealth; President, New York Biohub; Clyde and Helen Wu Professor of Chemical Programs Biology, Columbia College
“Single-cell transcriptomics supplies unprecedented decision of tumor heterogeneity, however understanding how these mobile states are established and maintained requires systems-level evaluation. By figuring out the Grasp Regulator proteins controlling every malignant state, we are able to transfer from describing tumor variety to defining actionable therapeutic vulnerabilities.”
— Pasquale Laise, PhD
Senior Director, Single-Cell Programs Pharmacology, DarwinHealth
“For many years, oncology has looked for higher medicine to deal with particular person cancers. Quantum Most cancers Biology begins with a special premise: that many superior tumors aren’t one most cancers, however many biologically distinct cancers coexisting throughout the similar affected person. Our mission is to decode these hidden mobile states and rework that information into rational—virtually invariably, mixture—therapeutic methods that focus on the total complement of regulatory community derangements.”
— Gideon Bosker, MD
Chief Government Officer and Co-Founder, DarwinHealth
A New Framework for Precision Oncology
DarwinHealth believes that Quantum Most cancers Biology: A Cell-State Programs Biology Framework for Precision Oncology represents a foundational advance in most cancers programs biology.
By integrating single-cell transcriptomics, regulatory community inference, inferential synthetic intelligence, and programs pharmacology, the framework seeks to determine the smallest rational mixture of therapeutic interventions able to focusing on the total spectrum of malignant mobile states inside every affected person’s tumor.
Initially developed and validated in pancreatic and mind most cancers, the framework is now being prolonged throughout further extremely resistant malignancies—together with glioblastoma and different aggressive strong tumors—with the aim of accelerating the event of more practical precision mixture therapies.
As oncology enters an period outlined by mobile decision slightly than inhabitants averages, DarwinHealth believes Quantum Most cancers Biology supplies the conceptual and computational basis for decoding most cancers’s hidden complexity—and translating that information into extra sturdy therapeutic outcomes.
